In our study, GC-MSCs expressed higher levels of VEGF, MIP-2, TGF-β1, IL-6, and IL-8 than GCN-MSCs or BM-MSCs did, suggesting a more potent role of GC-MSCs in tumor angiogenesis. This evidence concerns the gene IL6 and neoplasm.